Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus-Reference-Cited by-同舟云学术

Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus

Published:2017-09-11 Issue:6 Volume:14 Page:573-580
ISSN:1541-2555
Container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD: Journal of Chronic Obstructive Pulmonary Disease

Author:

García-Río Francisco¹²³,Soler-Cataluña Juan J²⁴,Alcazar Bernardino⁵,Viejo José L⁶,Miravitlles Marc²⁷^ORCID

Affiliation:

1. Servicio de Neumología, Hospital Universitario La Paz-IdiPAZ, Madrid

2. Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid

3. Universidad Autónoma de Madrid, Madrid

4. Servicio de Neumología, Hospital Arnau de Vilanova-Lliria, Valencia

5. Area Integrada de Gestión de Medicina, Hospital de Alta Resolución de Loja, Agencia Sanitaria Hospital de Poniente, Granada

6. Servicio de Neumología, Hospital Universitario de Burgos, Burgos

7. Servicio de Neumología, Hospital Universitari Vall d'Hebron, Barcelona, Spain

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15412555.2017.1365120

Reference39 articles.

1. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

2. Projections of Global Mortality and Burden of Disease from 2002 to 2030

3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

4. Guía española de la enfermedad pulmonar obstructiva crónica (GesEPOC) 2017. Tratamiento farmacológico en fase estable

5. Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat® Soft Mist™ Inhaler

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the effectiveness of inhalation therapy in patients with chronic airway diseases: A new digital measurement;Respiratory Medicine and Research;2024-11

2. Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2024-08-01

3. Inhaler Adherence in COPD: A Crucial Step Towards the Correct;International Journal of Chronic Obstructive Pulmonary Disease;2023-12

4. Plan de Intervención Comunitaria para el manejo de la EPOC estable: protocolo de coordinación asistencial y derivación entre farmacias comunitarias y centros de salud;Farmacéuticos Comunitarios;2022-10-21

5. FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy;International Journal of Chronic Obstructive Pulmonary Disease;2022-05